Effects of topically applied capsaicin on moderate and severe psoriasis vulgaris

doi:10.1016/S0190-9622(86)70201-6

Journal of the American Academy of Dermatology

Volume 15, Issue 3, September 1986, Pages 504-507

https://doi.org/10.1016/S0190-9622(86)70201-6 Get rights and content

Alterations in the cutaneous vascular system are prominent in psoriasis and may play an important role in the pathogenesis of this disorder. We evaluated the effects of topically applied capsaicin (trans-8-methyl-N-vanillyl-6-nonenamide), a known inhibitor of cutaneous vasodilatation, on moderate and severe psoriasis. Under a double-blind paradigm, forty-four patients with symmetrically distributed psoriatic lesions applied topical capsaicin to one side of their body and identical-appearing vehicle to the other side for 6 weeks. After 3 and 6 weeks of treatment, we performed ratings on changes in scaling and erythema, as well as overall improvement of the psoriasis. Over the course of the study, significantly greater overall improvement was observed on sides treated with capsaicin compared to sides treated with vehicle. Similarly, significantly greater reductions in scaling and erythema accompanied capsaicin application. Burning, stinging, itching, and redness of the skin were noted by nearly half of the patients on initial applications of study medication but diminished or vanished upon continued application. These results suggest that topical application of capsaicin may be a useful new approach in the treatment of psoriasis.

References (20)

P Telner et al.
The capillary responses in psoriatic skin
J Invest Dermatol
(1961)
H Pinkus et al.
The primary histologic lesion of seborrheic dermatitis and psoriasis
J Invest Dermatol
(1966)
IM Braverman
Electron microscopic studies of the microcirculation in psoriasis
J Invest Dermatol
(1972)
IM Braverman et al.
Microcirculation in psoriatic skin
J Invest Dermatol
(1974)
IM Braverman et al.
Role of the microcirculation in the treatment and pathogenesis of psoriasis
J Invest Dermatol
(1982)
JE Bernstein et al.
Inhibition of axon reflex vasodilatation by topically applied capsaicin
J Invest Dermatol
(1981)
TM Jessell et al.
Capsaicin-induced depletion of substance P from primary sensory neurones
Brain Res
(1978)
A Nyfors et al.
Cutaneous blood flow in psoriasis measured by xenon clearance
J Invest Dermatol
(1970)
PA DiLorenzo et al.
Technetium-99m pertechnetate disappearance studies in normal and psoriatic skin
J Invest Dermatol
(1971)
EM Farber et al.
Stress, symmetry, and psoriasis. Possible role of neuropeptides
J Am Acad Dermatol
(1986)

There are more references available in the full text version of this article.

Cited by (164)

Roles of calcitonin gene-related peptide in the skin, and other physiological and pathophysiological functions
2021, Brain, Behavior, and Immunity - Health
Citation Excerpt :
In addition to psoriasis, cutaneous sensory nerves are involved in other skin conditions such as allergic contact dermatitis (mouse model) and pruritus (Prignano et al., 2009; Wilson et al., 2011; Liu et al., 2013; Therene et al., 2018). Topical capsaicin led to depletion of sensory neuropeptides with repeated application-efficient in minimizing both psoriasis-associated skin lesions as well as cutaneous discomfort, albeit with initial burning as a side-effect (Bernstein et al., 1986). Although psoriasis treatments generally improve pruritus, this does not always correlate with lesion regression (Prignano et al., 2009; Therene et al., 2018).
Skin immunity is regulated by many mediator molecules. One is the neuropeptide calcitonin gene-related peptide (CGRP). CGRP has roles in regulating the function of components of the immune system including T cells, B cells, dendritic cells (DCs), endothelial cells (ECs), and mast cells (MCs).
Herein we discuss actions of CGRP in mediating inflammatory and vascular effects in various cutaneous models and disorders.
Capsaicin attenuates imiquimod-induced epidermal hyperplasia and cutaneous inflammation in a murine model of psoriasis
2021, Biomedicine and Pharmacotherapy
Citation Excerpt :
Results show that IL-23 production after imiquimod stimulation could be inhibited by topical application of capsaicin which arrests TRPV1 pathway, and this inhibition effect on psoriasiform inflammation could be by-passed by direct cutaneous injection of IL-23. These results serve as a potential expounder for an earlier clinical observation that topical capsaicin is able to bring improvement in a patient with psoriasis vulgaris [19]. The improvement of psoriasiform inflammation simply by epicutaneous delivery of capsaicin proposes a readily available, non-steroidal product with a high safety profile in treating psoriasiform dermatitis.
Psoriasis is one of the most common chronic inflammatory diseases that is characterized by well-defined erythematous plaques, with typical histopathological findings of lymphocytic infiltration and epidermal hyperplasia. Topical treatments of psoriasis are either associated with limited response or with side effects. Up to date, topicals targeting neuroimmune axis in psoriasis or psoriasiform dermatitis have not been explored. Here, we investigated whether percutaneous delivery of capsaicin could attenuate the pathological change of psoriasiform inflammation. Imiquimod-induced psoriasis-like murine model was used to evaluate therapeutic effects from topical application of capsaicin. An additional model of psoriasiform dermatitis induced by direct IL-23 injection was used to identify the level of action from capsaicin in this neuroimmune axis. Cutaneous inflammation was assessed by erythema level and ear thickness change. Key cytokines, infiltrating cells in the skin, and draining lymph node cells were investigated. The results showed that capsaicin administration obstructed the activation of IL-23/IL-17 pathway induced by imiquimod, presenting with significantly reduced psoriasiform dermatitis both in gross appearance and microscopic features. Tissue gene expression of psoriatic core cytokines induced by imiquimod (including IL-23, IL-17A, IL-22, TNF-α, and IL-6) were greatly decreased by capsaicin application. This protective effect from capsaicin could be hampered by direct intradermal injection of IL-23.
Epicutaneous delivery of capsaicin on imiquimod-treated murine skin could significantly decrease expression of multiple inflammatory cytokines and the severity of prototypic change of psoriasiform inflammation. The beneficial effect imposed by capsaicin reinforces the neuroimmune contribution towards psoriasiform inflammation and provides a potential non-steroidal therapeutic alternative for topical treatment of psoriasiform dermatitis.
Neurotransmitters, neuropeptides and their receptors interact with immune response in healthy and psoriatic skin
2020, Neuropeptides
Psoriasis is a chronic inflammatory disease with a multifactorial origin that affects the skin. It is characterized by keratinocyte hyperproliferation, which results in erythemato-squamous plaques. Just as the immune system plays a fundamental role in psoriasis physiopathology, the nervous system maintains the inflammatory process through the neuropeptides and neurotransmitters synthesis, as histamine, serotonin, calcitonin gene-related peptide, nerve growth factor, vasoactive intestinal peptide, substance P, adenosine, glucagon-like peptide, somatostatin and pituitary adenylate cyclase polypeptide. In patients with psoriasis, the systemic or in situ expression of these chemical mediators and their receptors are altered, which affects the clinical activity of patients due to its link to the immune system, provoking neurogenic inflammation. It is important to establish the role of the nervous system since it could represent a therapeutic alternative for psoriasis patients. The aim of this review is to offer a detailed review of the current literature about the neuropeptides and neurotransmitters involved in the physiopathology of psoriasis.
Chronic Social Stress Ameliorates Psoriasiform Dermatitis Through Upregulation of the Hypothalamic-Pituitary-Adrenal axis
2018, Brain, Behavior, and Immunity
Acute stress is a physiological response of an organism to adverse conditions, contributing to survival; however, persistence through time may lead to disease. Indeed, exacerbation of inflammatory conditions such as psoriasis has been reported to follow stressors in susceptible patients. Because chronic stress cannot ethically be elicited in patients under controlled laboratory conditions, we studied genetically modified mice that naturally develop psoriasiform dermatitis, and subjected them to an ethological chronic social contact stress paradigm. Although we found elevated pro-inflammatory neuropeptide production of substance P (SP), calcitonin-gene-related peptide (CGRP) and nerve-growth factor (NGF) mRNA in the dorsal root ganglia (DRG) as well as pro-inflammatory cytokines in response to the social stressor, stress paradoxically prevented the development of the skin lesions. This effect of stress could be reversed by the treatment with glucocorticoid (GC) receptor blockers, suggesting that it was mediated through the upregulation of corticosterone secretion. Extrapolating to humans, the worsening of disease in susceptible patients with psoriasis could be attributed to a defect in the Hypothalamic-Pituitary-Adrenal (HPA) axis with an impaired production of GC during situations of adversity, thus rendering them unable to counteract the pro-inflammatory effects of chronic stressors.
Pathophysiological Roles of Ion Channels in Epidermal Cells, Immune Cells, and Sensory Neurons in Psoriasis
2024, International Journal of Molecular Sciences
From Traditional Medicine to Advanced Therapeutics: The Renaissance of Phyto-nano Interventions in Psoriasis
2024, Recent Advances in Inflammation and Allergy Drug Discovery

View all citing articles on Scopus

View full text

Effects of topically applied capsaicin on moderate and severe psoriasis vulgaris

J Invest Dermatol

J Invest Dermatol

J Invest Dermatol

J Invest Dermatol

J Invest Dermatol

J Invest Dermatol

Brain Res

J Invest Dermatol

J Invest Dermatol

J Am Acad Dermatol